Magnesium citrate and Emgality drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium citrate (magnesium) and Emgality (galcanezumab-gnlm). Common drug interactions include muscle spasms among females and application site pain among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium citrate and Emgality. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium citrate?

Magnesium citrate has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 5,790 Magnesium citrate users. Check the latest studies of Magnesium citrate.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

13 people who take Magnesium citrate and Emgality together, and have interactions are studied.

Magnesium citrate and Emgality drug interactions.

What are the common drug interactions of Magnesium Citrate and Emgality, by gender? *:

female:

Muscle spasms (muscle contraction)
Abdominal distension
Diarrhoea
Flatulence (flatus expelled through the anus)
Glycosylated haemoglobin
Hypersensitivity
Hypoacusis (loss of hearing)
Injection site erythema (redness at injection site)
Injection site induration
Injection site pain

male:

Application site pain

What are the common drug interactions of Magnesium Citrate and Emgality, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Injection site pain
Lethargy (tiredness)
Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Muscular weakness (muscle weakness)
Nausea (feeling of having an urge to vomit)
Peripheral swelling
Rash
Tinnitus (a ringing in the ears)
Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

Application site pain

50-59:

Hypersensitivity
Hypoacusis (loss of hearing)
Muscle spasms (muscle contraction)
Weight increased

60+:

Asthenia (weakness)
Fall
Flatulence (flatus expelled through the anus)
Trigeminal neuralgia (a painful condition of the nerve responsible for most facial sensation)
Gait disturbance
Influenza
Infusion related reaction
Muscle spasms (muscle contraction)
Occipital neuralgia (a condition characterized by chronic pain in the upper neck)
Pain

What are the existing conditions these people have? *

Migraine (headache): 8 people, 61.54%
Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 2 people, 15.38%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 15.38%
Diabetes: 2 people, 15.38%
Fungal Infection: 2 people, 15.38%
Hypersensitivity: 2 people, 15.38%
Itching: 2 people, 15.38%
Lipids Increased (excess lipid in body): 2 people, 15.38%
Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 2 people, 15.38%
Depression: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium citrate and Emgality?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously